Interview with the Founder and Executive Chairman: Organovo Holdings Inc (NASDAQ:ONVO) twst.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from twst.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Viscient Biosciences ("Viscient") today announced that its scientists, along with collaborators from University of California, San Diego,.
/PRNewswire/ Viscient Bio, Inc. ("Viscient") today announced it has identified the world s first drug candidate discovered primarily using 3D bioprinted.
Organovo uses different 3D tissue technologies to see the best biology of the intestine, which gets us to the best novel therapeutics, new drugs for intestinal diseases, especially for Crohn’s disease and ulcerative colitis.